首页> 外文期刊>Journal of Experimental Pharmacology >Nephroprotection of lacidipine against gentamycin-induced nephrotoxicity in albino rats
【24h】

Nephroprotection of lacidipine against gentamycin-induced nephrotoxicity in albino rats

机译:拉西地平对庆大霉素诱导的白化病大鼠肾毒性的肾保护作用

获取原文
       

摘要

Aim: Gentamycin, a widely-used aminoglycoside antibiotic, is recognized as possessing significant nephrotoxic potential in human beings. Gentamycin-induced nephrotoxicity is suggested to be mediated via reactive oxygen species. The present study investigated the possible antioxidant nephroprotective effect of lacidipine as a calcium-channel blocker in a gentamycin-induced nephrotoxicity model in albino rats.Methods: Albino rats were divided into 3 groups. Group 1 received normal saline. Group 2 received gentamycin 80 mg/kg intraperitoneally for 14 days. Group 3 received lacidipine 1 mg/kg intraperitoneally 3 days before and 14 days concurrently with gentamycin. This dose does not affect the blood pressure of rats, as evidenced in the pilot study.Results: Gentamycin-induced nephrotoxicity was evidenced by a marked reduction in creatinine clearance. Treatment with lacidipine improved creatinine clearance compared to the gentamycin-treated group. In addition, it reduced thiobarbituric acid reactive substance, as an index of lipid peroxidation, with significant increases in superoxide dismutase enzyme in erythrocyte lysates and kidney catalase enzyme activities.Conclusion: This study recommends the use of lacidipine in prophylaxis against gentamycin induced nephrotoxicity.
机译:目的:庆大霉素是一种广泛使用的氨基糖苷类抗生素,被认为在人类中具有明显的肾毒性潜力。庆大霉素诱导的肾毒性被认为是通过活性氧介导的。本研究探讨了庆大霉素诱导的肾毒性模型中lacidipine作为钙通道阻滞剂的抗氧化肾保护作用。方法:将白化病大鼠分为3组。第1组接受生理盐水。第2组腹膜内接受庆大霉素80 mg / kg的剂量,持续14天。第3组在庆大霉素治疗前3天和14天同时腹腔注射拉米地平1 mg / kg。如初步研究中所证明,该剂量不会影响大鼠血压。结果:庆大霉素引起的肾毒性通过肌酐清除率的明显降低来证明。与庆大霉素治疗组相比,拉米地平治疗可改善肌酐清除率。此外,它减少了作为脂质过氧化指标的硫代巴比妥酸反应性物质,并显着增加了红细胞裂解液中的超氧化物歧化酶和肾脏过氧化氢酶的活性。结论:本研究建议使用拉地平来预防庆大霉素引起的肾毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号